TYROBP Protein (DAP12)

📖 Wiki Page

protein1246 wordssynced 2026-04-02

TYROBP Protein (DAP12)

Pathway Diagram

```mermaid
flowchart TD
TYROBP["TYROBP"]
TREM2["TREM2"]
SIRP1B["SIRP1B"]
microglia["Microglia"]
signal_transduction["Signal Transduction"]
brain_homeostasis["Brain Homeostasis"]
pathogen_phagocytosis["Pathogen Phagocytosis"]
synaptic_function["Synaptic Function"]
learning_behavior["Learning Behavior"]
immune_infiltration["Immune Cell Infiltration"]
alzheimers["Alzheimer Disease"]
late_onset_ad["Late-Onset AD"]
tauopathy["Tauopathy"]
als["ALS"]
aging["Aging"]

TREM2 --"forms complex"--> TYROBP
TYROBP --"receptor binding"--> SIRP1B
microglia --"expresses"--> TYROBP
TYROBP --"mediates"--> signal_transduction
TYROBP --"maintains"--> brain_homeostasis
TYROBP --"regulates"--> pathogen_phagocytosis
TYROBP --"modulates"--> synaptic_function
TYROBP --"influences"--> learning_behavior
TYROBP --"promotes"--> immune_infiltration
TYROBP --"associated with"--> alzheimers
TYROBP --"risk factor"--> late_onset_ad
TYROBP --"expressed in"--> tauopathy
TYROBP --"activates"--> als
TYROBP --"regulates"--> aging

style TYROBP fill:#006494
style brain_homeostasis fill:#1b5e20
style pathogen_phagocytosis fill:#1b5e20
style synaptic_function fill:#1b5e20
style learning_behavior fill:#1b5e20
style immune_infiltration fill:#ef5350
style alzheimers fill:#ef5350
style late_onset_ad fill:#ef5350
style tauopathy fill:#ef5350
style als fill:#ef5350
style aging fill:#ef5350
style signal_transd

...

TYROBP Protein (DAP12)

Pathway Diagram

Mermaid diagram (expand to render)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TYROBP Protein (DAP12)</th>
</tr>
<tr>
<td class="label">Receptor</td>
<td>Cell Type</td>
</tr>
<tr>
<td class="label">[TREM2](/proteins/trem2)</td>
<td>[Microglia](/cell-types/microglia-neuroinflammation)</td>
</tr>
<tr>
<td class="label">TREM1</td>
<td>Myeloid cells</td>
</tr>
<tr>
<td class="label">SIRPbeta1</td>
<td>Macrophages</td>
</tr>
<tr>
<td class="label">MDL-1</td>
<td>Myeloid cells</td>
</tr>
<tr>
<td class="label">NKp44</td>
<td>NK cells</td>
</tr>
<tr>
<td class="label">SIGLEC-15</td>
<td>Osteoclasts</td>
</tr>
<tr>
<td class="label">Agent</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">AL002 (Gantenerumab-like)</td>
<td>Anti-TREM2 agonist mAb</td>
</tr>
<tr>
<td class="label">DAP12 agonist antibodies</td>
<td>Direct DAP12 activation</td>
</tr>
<tr>
<td class="label">Soluble TREM2</td>
<td>Enhances DAP12 signaling</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Type</td>
</tr>
<tr>
<td class="label">TREM2</td>
<td>Receptor</td>
</tr>
<tr>
<td class="label">TREM1</td>
<td>Receptor</td>
</tr>
<tr>
<td class="label">SYK</td>
<td>Kinase</td>
</tr>
<tr>
<td class="label">ZAP70</td>
<td>Kinase</td>
</tr>
<tr>
<td class="label">PI3K</td>
<td>Kinase</td>
</tr>
<tr>
<td class="label">SRC kinases</td>
<td>Kinase</td>
</tr>
<tr>
<td class="label">GRB2</td>
<td>Adaptor</td>
</tr>
<tr>
<td class="label">PLCgamma</td>
<td>Enzyme</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">Alzheimer's Disease</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">117 edges</a></td>
</tr>
</table>

<div style="float: right; width: 280px; background: #f8f9fa; padding: 12px; border: 1px solid #ddd; border-radius: 4px; margin: 0 0 1em 1em; font-size: 0.9em;">
<h3 style="margin-top: 0; border-bottom: 1px solid #ccc;">TYROBP Protein</h3>
<table style="width: 100%; border-collapse: collapse;">
<tr><td style="padding: 4px 0;"><strong>Symbol:</strong></td><td>TYROBP</td></tr>
<tr><td style="padding: 4px 0;"><strong>Also known as:</strong></td><td>DAP12, KARAP, PLOSL</td></tr>
<tr><td style="padding: 4px 0;"><strong>UniProt:</strong></td><td>[O43914](https://www.uniprot.org/uniprot/O43914)</td></tr>
<tr><td style="padding: 4px 0;"><strong>Gene:</strong></td><td>[TYROBP](/genes/tyrobp)</td></tr>
<tr><td style="padding: 4px 0;"><strong>MW:</strong></td><td>12.1 kDa</td></tr>
<tr><td style="padding: 4px 0;"><strong>Location:</strong></td><td>Cell membrane</td></tr>
<tr><td style="padding: 4px 0;"><strong>PDB:</strong></td><td>[1L1Y](https://www.rcsb.org/structure/1L1Y), [2L8H](https://www.rcsb.org/structure/2L8H)</td></tr>
</table>
</div>

Overview

TYROBP (TYRO Protein Tyrosine Kinase-Binding Protein), commonly known as DAP12 (DNAX-Activation Protein 12), is a transmembrane signaling adaptor protein that plays critical roles in innate immunity and microglial function in the central nervous system. DAP12 partners with multiple immunoreceptors, most notably [TREM2](/proteins/trem2), to transduce activation signals that regulate microglial survival, phagocytosis, and inflammatory responses[@lanier1998].

Mutations in TYROBP cause Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy, PLOSL), a rare autosomal recessive disorder characterized by presenile dementia and bone cysts. Additionally, DAP12 signaling is increasingly recognized as a key pathway in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions[@paloneva2000][@colonna2003].

Structure and Domain Architecture

TYROBP is a small 113-amino acid type I transmembrane protein:

Extracellular Domain (residues 1-35):

Very short extracellular region
Contains cysteine residues for disulfide linkage to partner receptors
Mediates non-covalent association with receptor partners

Transmembrane Domain (residues 36-56):

Single α-helix with a critical aspartic acid residue (Asp50)
Asp50 forms a salt bridge with a lysine in the partner receptor's transmembrane domain
This electrostatic interaction drives receptor-adaptor pairing[@feng2010]

Cytoplasmic Domain (residues 57-113):

Contains the ITAM (Immunoreceptor Tyrosine-based Activation Motif)
ITAM sequence: YxxL/I...YxxL/I (Tyr71 and Tyr86)
Phosphorylation sites that recruit SYK and ZAP70 kinases

Receptor Partners

DAP12 pairs with multiple receptors in different cell types:

Normal Function in the CNS

Microglial Signaling

In microglia, DAP12 primarily partners with TREM2 to regulate:

Phagocytosis: DAP12-TREM2 signaling promotes clearance of:

Apoptotic [neurons](/entities/neurons)
Amyloid-β aggregates
Myelin debris
Protein aggregates[@hsieh2009]

Cell Survival: PI3K/AKT pathway activation downstream of DAP12 promotes microglial survival.

Migration: Chemotactic responses to damage signals require DAP12 signaling.

Metabolism: DAP12 regulates microglial metabolic adaptation during activation[@ulland2017].

Proliferation: CSF1R-induced microglial proliferation is modulated by DAP12.

Signal Transduction

The canonical DAP12 signaling cascade involves:

Ligand binding to the partner receptor (e.g., TREM2 binding anionic lipids, Aβ)

Receptor clustering and conformational change

Src-family kinase phosphorylation of ITAM tyrosines

SYK recruitment via SH2 domains

Downstream activation of:

PI3K/AKT pathway
PLCγ/Ca2+ signaling
RAS/RAF/ERK cascade
[NF-κB](/entities/nf-kb) transcription[@turnbull2006]

Role in Neurodegeneration

Nasu-Hakola Disease (TYROBP Mutations)

Biallelic loss-of-function mutations in TYROBP cause Nasu-Hakola disease:

Clinical Features:

Bone cysts and fractures (onset 20s-30s)
Progressive cognitive decline (onset 30s-40s)
Presenile dementia
White matter changes on MRI[@paloneva2002]

Pathology:

Diffuse white matter degeneration
Astrogliosis and microglial abnormalities
No typical AD pathology (no [Aβ](/proteins/amyloid-beta) plaques, [tau](/proteins/tau) tangles)

Mechanism: Loss of DAP12 function leads to:

Impaired microglial phagocytosis
Defective clearance of myelin debris
Accumulation of toxic lipids
White matter degeneration[@thrash2009]

Alzheimer's Disease

DAP12-TREM2 signaling is critical in AD:

TREM2 Risk Variants: AD-associated TREM2 variants (R47H, R62H) impair DAP12 signaling.

Microglial Response to Aβ: DAP12 is required for:

Microglial clustering around Aβ plaques
Phagocytic clearance of Aβ
Formation of a protective barrier around plaques[@wang2015]

DAM (Disease-Associated Microglia): The transcriptional shift to DAM phenotype requires intact DAP12-TREM2 signaling.

Neuroinflammation: DAP12 can also promote inflammatory responses that may be detrimental.

Synaptic Pruning: DAP12-TREM2 regulates complement-mediated synaptic pruning in AD[@filipello2018].

Parkinson's Disease

DAP12 involvement in PD includes:

[α-Synuclein](/proteins/alpha-synuclein) Response: DAP12-TREM2 signaling regulates microglial responses to α-synuclein aggregates.

Neuroinflammation: DAP12 contributes to microglial activation in PD.

Neuroprotection: Some studies suggest DAP12 activation may be protective by promoting aggregate clearance[@guerreiro2013].

Multiple Sclerosis

In MS, DAP12 plays roles in:

Myelin Phagocytosis: DAP12 regulates microglial clearance of myelin debris.

Remyelination: Impaired DAP12 signaling may slow remyelination.

Neuroinflammation: DAP12 contributes to inflammatory responses in active lesions[@takahashi2005].

Therapeutic Targeting

DAP12-TREM2 Agonists

Targeting Strategies

Receptor Agonists: Antibodies that cluster TREM2 and activate DAP12.

Soluble Ligands: Recombinant proteins that enhance DAP12-TREM2 signaling.

Small Molecule Activators: Compounds that enhance SYK activation downstream of DAP12[@schlepckow2020].

Gene Therapy: Increasing TYROBP or TREM2 expression in microglia.

Challenges

Balancing Activation: Overactivation may cause excessive inflammation.

Isoform Specificity: Need to target specific receptor-DAP12 pairs.

Timing: Optimal intervention window unclear.

Cell Type Effects: DAP12 is expressed in many immune cells; systemic effects possible[@chenghathaway2018].

Key Interactions

References

[Lanier LL, Corliss BC, Wu J, et al, Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells (1998)](https://doi.org/10.1038/35642)

[Paloneva J, Kestilä M, Wu J, et al, Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts (2000)](https://doi.org/10.1038/77153)

[Colonna M, TREMs in the immune system and beyond (2003)](https://doi.org/10.1038/nri1106)

[Feng J, Call ME, Wucherpfennig KW, The assembly of DAP12-TREM2 complex (2010)](https://doi.org/10.1016/j.immuni.2010.05.008)

[Hsieh CL, Koike M, Spusta SC, et al, A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia (2009)](https://doi.org/10.1111/j.1471-4159.2009.06042.x)

[Ulland TK, Song WM, Huang SC, et al, TREM2 maintains microglial metabolic fitness in Alzheimer's disease (2017)](https://doi.org/10.1016/j.cell.2017.07.023)

[Turnbull IR, Gilfillan S, Cella M, et al, Cutting edge: TREM-2 attenuates macrophage activation (2006)](https://doi.org/10.4049/jimmunol.177.6.3520)

[Paloneva J, Manninen T, Christman G, et al, Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype (2002)](https://doi.org/10.1086/342259)

[Thrash JC, Torbett BE, Carson MJ, Developmental regulation of TREM2 in the microglial response to neonatal hypoxia-ischemia (2009)](https://doi.org/10.1159/000232557)

[Wang Y, Cella M, Mallinson K, et al, TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model (2015)](https://doi.org/10.1016/j.cell.2015.01.049)

[Filipello F, Morini R, Corradini I, et al, The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity (2018)](https://doi.org/10.1016/j.immuni.2018.04.016)

[Guerreiro R, Wojtas A, Bras J, et al, TREM2 variants in Alzheimer's disease (2013)](https://doi.org/10.1056/NEJMoa1211851)

[Takahashi K, Rochford CD, Neumann H, Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2 (2005)](https://doi.org/10.1084/jem.20041611)

[Schlepckow K, Monroe KM, Kleinberger G, et al, Enhancing TREM2 activity as a therapeutic approach (2020)](https://doi.org/10.15252/emmm.201911227)

[Cheng-Hathaway PJ, Reed-Geaghan EG, Jay TR, et al, The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer's disease (2018)](https://doi.org/10.1186/s13024-018-0262-0)

Pathway Diagram

The following diagram shows the key molecular relationships involving TYROBP Protein (DAP12) discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

TYROBP Protein (DAP12)

TYROBP Protein (DAP12)

Pathway Diagram

TYROBP Protein (DAP12)

Pathway Diagram

Overview

Structure and Domain Architecture

Receptor Partners

Normal Function in the CNS

Microglial Signaling

Signal Transduction

Role in Neurodegeneration

Nasu-Hakola Disease (TYROBP Mutations)

Alzheimer's Disease

Parkinson's Disease

Multiple Sclerosis

Therapeutic Targeting

DAP12-TREM2 Agonists

Targeting Strategies

Challenges

Key Interactions

See Also

References

Pathway Diagram